Income Statement Amoéba

Stocks

ALMIB

FR0011051598

Agricultural Chemicals

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-06-11 am EDT			5-day change	1st Jan Change
0.7850 ^EUR	-4.50%		-9.35%	-25.80%

Jun. 08	Amoéba secures strategic emergency authorization in Italy
May. 06	Amoéba Announces Two New Exceptional Trial Permits for Biocontrol Solution in the Netherlands	CI

f5c2d619d400f.jBT3lSQzlzDfYs9fzsJEcZzlQmv-N9-xPPYULScbmTk.uiWnpWtYxmmnVIBrgvooFPuTECCGb-ecC6IlcmRU-Gj7OYGjbVfxYKkPrA

Published financial data: AMOÉBA

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	-	-	-	602K	695K
Total Revenues	-	-	-	602K	695K
Cost of Goods Sold, Total	767K	1.11M	1.71M	1.48M	2.57M
Gross Profit	-767K	-1.11M	-1.71M	-877K	-1.87M
Selling General & Admin Expenses, Total	3.21M	2.67M	3.27M	3.14M	3.33M
R&D Expenses	1.61M	2.06M	1.66M	1.65M	1.57M
Other Operating Expenses	-	-	7.4M	-	-
Other Operating Expenses, Total	4.81M	4.73M	12.33M	4.79M	4.91M
Operating Income	-5.58M	-5.84M	-14.04M	-5.66M	-6.78M
Interest Expense, Total	-2.35M	-1.61M	-146K	-928K	-1.53M
Interest And Investment Income	28.93K	-	-	-	-
Net Interest Expenses	-2.32M	-1.61M	-146K	-928K	-1.53M
Currency Exchange Gains (Loss)	47.21K	20.37K	-1.78K	-	72.51K
Other Non Operating Income (Expenses)	31.4K	-593K	-112K	-	-66.2K
EBT, Excl. Unusual Items	-7.82M	-8.02M	-14.3M	-6.59M	-8.3M
Restructuring Charges	-	-	-	-	-
Asset Writedown	-	-	-	-	-
EBT, Incl. Unusual Items	-7.82M	-8.02M	-14.3M	-6.59M	-8.3M
Earnings From Continuing Operations	-7.82M	-8.02M	-14.3M	-6.59M	-8.3M
Net Income to Company	-7.82M	-8.02M	-14.3M	-6.59M	-8.3M
Net Income - (IS)	-7.82M	-8.02M	-14.3M	-6.59M	-8.3M
Net Income to Common Incl Extra Items	-7.82M	-8.02M	-14.3M	-6.59M	-8.3M
Net Income to Common Excl. Extra Items	-7.82M	-8.02M	-14.3M	-6.59M	-8.3M
Per Share Items
Net EPS - Basic	-0.44	-0.24	-0.29	-0.13	-0.14
Basic EPS - Continuing Operations	-0.44	-0.24	-0.29	-0.13	-0.14
Basic Weighted Average Shares Outstanding	17.78M	33.57M	49.28M	49.63M	58.81M
Net EPS - Diluted	-0.44	-0.24	-0.29	-0.13	-0.14
Diluted EPS - Continuing Operations	-0.44	-0.24	-0.29	-0.13	-0.14
Diluted Weighted Average Shares Outstanding	17.78M	33.57M	49.28M	49.63M	58.81M
Normalized Basic EPS	-0.27	-0.15	-0.18	-0.08	-0.09
Normalized Diluted EPS	-0.27	-0.15	-0.18	-0.08	-0.09
Supplemental Items
EBITDA	-5.05M	-5.35M	-13.47M	-5.12M	-6.09M
EBITA	-5.57M	-5.84M	-14.02M	-5.62M	-6.78M
EBIT	-5.58M	-5.84M	-14.04M	-5.66M	-6.78M
EBITDAR	-5.03M	-5.28M	-13.44M	-5.04M	-6.04M
Normalized Net Income	-4.89M	-5.01M	-8.94M	-4.12M	-5.19M
Interest Capitalized	1.64M	973K	9.8K	24K	37K
Interest on Long-Term Debt	2.34M	1.6M	146K	928K	1.53M
Non-Cash Pension Expense	125	351	370	553	827
Supplemental Operating Expense Items
Selling and Marketing Expenses	225K	390K	354K	409K	625K
General and Administrative Expenses	2.96M	2.21M	2.88M	2.65M	2.66M
Research And Development Expense From Footnotes	2.18M	2.53M	2.32M	1.65M	1.57M
Net Rental Expense, Total	23.79K	71.14K	33.88K	79.73K	48.21K
Imputed Operating Lease Interest Expense	71.94K	198K	11.58K	71.51K	49.58K
Imputed Operating Lease Depreciation	-48.16K	-127K	22.3K	8.22K	-1.37K
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	22.43K	37.97K	-	117K	304K
Total Stock-Based Compensation	22.43K	37.97K	-	117K	304K

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	7.28M	5.53M	519K	459K	4.72M
Total Cash And Short Term Investments	7.28M	5.53M	519K	459K	4.72M
Accounts Receivable, Total	8.33K	7.59K	5.75K	648	2.22K
Other Receivables	773K	734K	1.76M	1.34M	1.21M
Total Receivables	781K	742K	1.76M	1.34M	1.21M
Inventory	253K	281K	203K	257K	546K
Prepaid Expenses	131K	123K	136K	121K	184K
Other Current Assets, Total	8.65K	457K	4.86K	5.31K	44.64K
Total Current Assets	8.45M	7.13M	2.63M	2.18M	6.71M
Gross Property Plant And Equipment	8.75M	8.88M	12.03M	12.26M	15.21M
Accumulated Depreciation	-5.23M	-6.29M	-8.64M	-9.14M	-11.89M
Net Property Plant And Equipment	3.51M	2.59M	3.39M	3.13M	3.32M
Long-term Investments	611	-	220	-	-
Other Intangibles, Total	1	1.22K	38.7K	-	-
Deferred Charges Long-Term	2.48M	2.48M	0	-	-
Other Long-Term Assets, Total	69K	205K	228K	345K	108K
Total Assets	14.52M	12.4M	6.29M	5.65M	10.13M
Liabilities
Accounts Payable, Total	1.03M	1.3M	1.38M	1.39M	1.01M
Accrued Expenses, Total	373K	357K	310K	266K	381K
Short-term Borrowings	11.99M	2.06M	1.01K	527	554
Current Portion of Long-Term Debt	-	-	1.85M	2M	3.5M
Current Portion of Leases	238K	241K	280K	227K	127K
Current Income Taxes Payable	24.62K	43.26K	46.42K	23.11K	11.03K
Unearned Revenue Current, Total	-	-	-	-	1M
Other Current Liabilities	96.53K	163K	2.61M	1.29M	818K
Total Current Liabilities	13.75M	4.16M	6.48M	5.2M	6.85M
Long-Term Debt	-1	-	2.33M	9.56M	8.52M
Long-Term Leases	269K	54.55K	467K	280K	89.16K
Unearned Revenue Non Current	-	-	-	-	-
Pension & Other Post Retirement Benefits	44.41K	9.86K	17.26K	24.69K	36.52K
Other Non Current Liabilities	237K	-1	943K	1M	-1
Total Liabilities	14.3M	4.23M	10.23M	16.06M	15.49M
Common Stock, Total	409K	926K	993K	993K	1.38M
Additional Paid In Capital	45.82M	17.41M	13.12M	13.12M	25.76M
Retained Earnings	-7.82M	-8.02M	-14.3M	-6.59M	-8.3M
Comprehensive Income and Other	-38.2M	-2.14M	-3.76M	-17.93M	-24.2M
Total Common Equity	214K	8.18M	-3.94M	-10.41M	-5.36M
Total Equity	214K	8.18M	-3.94M	-10.41M	-5.36M
Total Liabilities And Equity	14.52M	12.4M	6.29M	5.65M	10.13M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	22.55M	46.28M	49.62M	49.63M	68.89M
ECS Total Common Shares Outstanding	20.42M	46.28M	49.62M	49.63M	68.89M
Book Value / Share	0.01	0.18	-0.08	-0.21	-0.08
Tangible Book Value	214K	8.18M	-3.98M	-10.41M	-5.36M
Tangible Book Value Per Share	0.01	0.18	-0.08	-0.21	-0.08
Total Debt	12.5M	2.36M	4.92M	12.07M	12.24M
Net Debt	5.22M	-3.17M	4.4M	11.61M	7.52M
Debt Equivalent Oper. Leases	190K	569K	271K	638K	386K
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	462K	437K	287K	308K	559K
Land - (BS)	-	-	1.03M	1.03M	1.03M
Machinery, Total	2.75M	2.86M	2.54M	6.03M	4.99M
Full Time Employees	18	22	22	20	23

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-7.82M	-8.02M	-14.3M	-6.59M	-8.3M
Depreciation & Amortization - CF	913K	1.12M	1.04M	738K	934K
Amortization of Goodwill and Intangible Assets - (CF)	6.33K	1.26K	16.45K	38.7K	-
Depreciation & Amortization, Total	920K	1.12M	1.06M	776K	934K
Amortization of Deferred Charges, Total - (CF)	89.56K	-	-	-	-
(Gain) Loss From Sale Of Asset	-	-	8.31K	17.72K	-
Stock-Based Compensation (CF)	22.43K	37.97K	-	117K	304K
Other Operating Activities, Total	2.97M	2.15M	7.63M	991K	1.54M
Change In Accounts Receivable	-2.32K	741	1.85K	5.1K	-1.57K
Change In Inventories	-151K	-27.94K	77.53K	-53.94K	-289K
Change In Accounts Payable	-96.63K	267K	88.02K	5.12K	-380K
Change In Income Taxes	-180K	3.49K	-44.74K	-66.69K	103K
Change in Other Net Operating Assets	-9.51K	45.7K	-1.03M	585K	3.43K
Cash from Operations	-4.26M	-4.43M	-6.5M	-4.22M	-6.09M
Capital Expenditure	-145K	-303K	-6.03M	-565K	-862K
Sale (Purchase) of Intangible assets	-	-2.47K	-49.61K	-	-
Investment in Marketable and Equity Securities, Total	3.92K	9.48K	-33.13K	11.22K	-6.9K
Other Investing Activities, Total	-	84.05K	3.31M	-1.46M	-434K
Cash from Investing	-141K	-212K	-2.81M	-2.01M	-1.3M
Long-Term Debt Issued, Total	10.14M	10.56M	3.52M	6.43M	3.98M
Total Debt Issued	10.14M	10.56M	3.52M	6.43M	3.98M
Long-Term Debt Repaid, Total	-3.51M	-6.54M	-252K	-241K	-308K
Total Debt Repaid	-3.51M	-6.54M	-252K	-241K	-308K
Issuance of Common Stock	-	-	-	-	-
Other Financing Activities, Total	-1.65M	-1.12M	1.03M	-24.44K	7.99M
Cash from Financing	4.98M	2.89M	4.3M	6.16M	11.66M
Foreign Exchange Rate Adjustments	749	923	-450	518	-1.04K
Miscellaneous Cash Flow Adjustments	1	-	-	-1	-
Net Change in Cash	583K	-1.75M	-5.01M	-59.92K	4.26M
Supplemental Items
Cash Interest Paid	1.65M	973K	9.78K	24.44K	36.99K
Levered Free Cash Flow	-4.18M	-3.9M	-11.91M	-4.78M	-4.84M
Unlevered Free Cash Flow	-2.71M	-2.89M	-11.81M	-4.2M	-3.88M
Change In Net Working Capital	115K	91.33K	-1.98M	989K	18.22K
Net Debt Issued / Repaid	6.62M	4.02M	3.27M	6.19M	3.67M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-25.25	-27.13	-93.88	-59.3	-53.73
Return on Total Capital	-29.85	-31.42	-152.4	-268.65	-99.38
Return On Equity %	-695.13	-191.24	-675.58	91.84	105.29
Return on Common Equity	-695.13	-191.24	-675.58	91.84	105.29
Margin Analysis
Gross Profit Margin %	-	-	-	-145.71	-269.51
SG&A Margin	-	-	-	521.95	479.53
EBITDA Margin %	-	-	-	-850.85	-875.73
EBITA Margin %	-	-	-	-934.9	-975.45
EBIT Margin %	-	-	-	-941.34	-975.45
Income From Continuing Operations Margin %	-	-	-	-1.1K	-1.19K
Net Income Margin %	-	-	-	-1.1K	-1.19K
Net Avail. For Common Margin %	-	-	-	-1.1K	-1.19K
Normalized Net Income Margin	-	-	-	-684.79	-746.16
Levered Free Cash Flow Margin	-	-	-	-794.54	-695.3
Unlevered Free Cash Flow Margin	-	-	-	-698.09	-558.23
Asset Turnover
Asset Turnover	-	-	-	0.1	0.09
Fixed Assets Turnover	-	-	-	0.18	0.22
Receivables Turnover (Average Receivables)	-	-	-	188.18	484.97
Inventory Turnover (Average Inventory)	4.32	4.16	7.06	6.42	6.4
Short Term Liquidity
Current Ratio	0.61	1.71	0.41	0.42	0.98
Quick Ratio	0.59	1.51	0.35	0.35	0.87
Operating Cash Flow to Current Liabilities	-0.31	-1.06	-1	-0.81	-0.89
Days Sales Outstanding (Average Receivables)	-	-	-	1.94	0.75
Days Outstanding Inventory (Average Inventory)	84.39	87.73	51.67	56.97	57.02
Average Days Payable Outstanding	428.33	373.04	299.81	331.17	153.03
Cash Conversion Cycle (Average Days)	-	-	-	-272.25	-95.26
Long Term Solvency
Total Debt/Equity	5.85K	28.84	-124.84	-115.9	-228.28
Total Debt / Total Capital	98.32	22.38	502.6	728.89	177.95
LT Debt/Equity	125.76	0.67	-70.83	-94.5	-160.55
Long-Term Debt / Total Capital	2.11	0.52	285.17	594.33	125.15
Total Liabilities / Total Assets	98.53	34.08	162.74	284.21	152.91
EBIT / Interest Expense	-2.38	-3.64	-96.31	-6.1	-4.45
EBITDA / Interest Expense	-1.99	-2.94	-89.04	-5.26	-3.84
(EBITDA - Capex) / Interest Expense	-2.05	-3.13	-130.44	-5.87	-4.4
Total Debt / EBITDA	-2.68	-0.5	-0.38	-2.47	-2.09
Net Debt / EBITDA	-1.12	0.67	-0.34	-2.38	-1.28
Total Debt / (EBITDA - Capex)	-2.6	-0.47	-0.26	-2.21	-1.82
Net Debt / (EBITDA - Capex)	-1.09	0.63	-0.23	-2.13	-1.12
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-	-	-9.44	15.6
Gross Profit, 1 Yr. Growth %	-21.62	44.73	53.99	-16.06	113.81
EBITDA, 1 Yr. Growth %	-6.23	5.83	151.96	-62	18.98
EBITA, 1 Yr. Growth %	-9.17	4.84	140.02	-59.89	20.61
EBIT, 1 Yr. Growth %	-9.38	4.74	140.25	-59.66	19.79
Earnings From Cont. Operations, 1 Yr. Growth %	-4.17	2.63	78.22	-53.9	25.96
Net Income, 1 Yr. Growth %	-4.17	2.63	78.22	-53.9	25.96
Normalized Net Income, 1 Yr. Growth %	-4.17	2.63	78.22	-53.9	25.96
Diluted EPS Before Extra, 1 Yr. Growth %	-12.6	-45.45	20.88	-54.22	6.29
Accounts Receivable, 1 Yr. Growth %	38.53	-8.89	-24.31	-88.72	242.59
Inventory, 1 Yr. Growth %	148.26	11.05	-27.63	26.55	112.35
Net Property, Plant and Equip., 1 Yr. Growth %	-18.29	-26.44	31.26	-7.87	6.08
Total Assets, 1 Yr. Growth %	10.82	-14.55	-49.32	-10.11	79.29
Tangible Book Value, 1 Yr. Growth %	-89.47	3.73K	-148.72	161.37	-48.5
Common Equity, 1 Yr. Growth %	-89.5	3.73K	-148.23	163.94	-48.5
Cash From Operations, 1 Yr. Growth %	30.92	4.07	46.84	-35.18	44.45
Capital Expenditures, 1 Yr. Growth %	136.99	109.72	1.89K	-90.64	52.69
Levered Free Cash Flow, 1 Yr. Growth %	56.44	7.33	205.61	-59.85	1.16
Unlevered Free Cash Flow, 1 Yr. Growth %	102.8	33.65	308.65	-64.45	-7.56
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-	-	2.32
Gross Profit, 2 Yr. CAGR %	15.49	6.51	49.29	-11.11	33.97
EBITDA, 2 Yr. CAGR %	13.17	-0.38	63.3	-2.16	-32.76
EBITA, 2 Yr. CAGR %	10.75	-2.42	58.63	-1.88	-30.44
EBIT, 2 Yr. CAGR %	10.45	-2.57	58.63	-1.55	-30.49
Earnings From Cont. Operations, 2 Yr. CAGR %	3.84	-0.83	35.24	-9.36	-23.8
Net Income, 2 Yr. CAGR %	3.84	-0.83	35.24	-9.36	-23.8
Normalized Net Income, 2 Yr. CAGR %	11.25	-0.83	35.24	-9.36	-23.8
Diluted EPS Before Extra, 2 Yr. CAGR %	-30.84	-30.95	-18.8	-25.61	-30.24
Accounts Receivable, 2 Yr. CAGR %	18.05	12.34	-16.96	-70.79	-37.85
Inventory, 2 Yr. CAGR %	70.98	66.04	-10.35	-4.3	63.93
Net Property, Plant and Equip., 2 Yr. CAGR %	-17.01	-22.47	-1.73	9.97	-1.14
Total Assets, 2 Yr. CAGR %	2.34	-2.69	-34.19	-32.5	26.95
Tangible Book Value, 2 Yr. CAGR %	-77.5	100.73	331.73	12.84	16.02
Common Equity, 2 Yr. CAGR %	-77.57	100.43	329.62	12.83	16.59
Cash From Operations, 2 Yr. CAGR %	11.22	16.72	23.62	-2.44	-3.24
Capital Expenditures, 2 Yr. CAGR %	43.13	122.94	546	36.47	-62.2
Levered Free Cash Flow, 2 Yr. CAGR %	44.23	20.73	81.11	10.77	-36.27
Unlevered Free Cash Flow, 2 Yr. CAGR %	68.84	46.96	133.7	20.52	-42.68
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	-	-
Gross Profit, 3 Yr. CAGR %	-4.09	24.52	20.44	4.57	19.1
EBITDA, 3 Yr. CAGR %	2.19	10.67	35.73	0.44	4.44
EBITA, 3 Yr. CAGR %	1.14	8.74	31.72	0.31	5.11
EBIT, 3 Yr. CAGR %	0.78	8.52	31.63	0.5	5.1
Earnings From Cont. Operations, 3 Yr. CAGR %	2.67	3.44	20.57	-5.53	1.15
Net Income, 3 Yr. CAGR %	2.67	3.44	20.57	-5.53	1.15
Normalized Net Income, 3 Yr. CAGR %	5.11	8.3	20.57	-5.53	1.15
Diluted EPS Before Extra, 3 Yr. CAGR %	-28.5	-36.1	-16.78	-32.92	-16.21
Accounts Receivable, 3 Yr. CAGR %	-26.51	8.29	-1.51	-57.32	-33.63
Inventory, 3 Yr. CAGR %	-14.05	48.07	25.9	0.57	24.82
Net Property, Plant and Equip., 3 Yr. CAGR %	-14.62	-20.28	-7.6	-3.82	8.66
Total Assets, 3 Yr. CAGR %	1.4	-3.63	-21.71	-26.98	-6.52
Tangible Book Value, 3 Yr. CAGR %	-65.83	24.66	25.21	265.23	-13.12
Common Equity, 3 Yr. CAGR %	-65.95	24.4	24.67	265.23	-13.13
Cash From Operations, 3 Yr. CAGR %	-7.23	8.79	26	-0.32	11.2
Capital Expenditures, 3 Yr. CAGR %	31.83	62.57	362.45	57.48	41.67
Levered Free Cash Flow, 3 Yr. CAGR %	7.18	24.68	64.54	9.61	7.47
Unlevered Free Cash Flow, 3 Yr. CAGR %	-0.21	44.8	106.66	24.75	10.32
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	37.48	-
Gross Profit, 5 Yr. CAGR %	10.97	17.31	14.48	8.81	13.89
EBITDA, 5 Yr. CAGR %	-1.77	0.3	23.26	5.35	2.48
EBITA, 5 Yr. CAGR %	-0.62	-0.23	21.09	4.36	2.03
EBIT, 5 Yr. CAGR %	-0.61	-0.41	20.83	4.37	1.96
Earnings From Cont. Operations, 5 Yr. CAGR %	6.27	5.18	14.63	-1.89	0.35
Net Income, 5 Yr. CAGR %	6.27	5.18	14.63	-1.89	0.35
Normalized Net Income, 5 Yr. CAGR %	6.27	5.18	16.26	0.86	0.35
Diluted EPS Before Extra, 5 Yr. CAGR %	-15.17	-25.42	-24.77	-32.1	-22.45
Accounts Receivable, 5 Yr. CAGR %	12.4	-16.39	-22.83	-35.88	-18.08
Inventory, 5 Yr. CAGR %	-16.36	-15.53	-12.59	24.35	39.92
Net Property, Plant and Equip., 5 Yr. CAGR %	-1.42	-16.65	-9.68	-9.33	-5.07
Total Assets, 5 Yr. CAGR %	-9.04	-10.48	-14.7	-16.43	-5.01
Tangible Book Value, 5 Yr. CAGR %	-59.08	-8.09	-5.75	19.79	21.45
Common Equity, 5 Yr. CAGR %	-59.08	-8.17	-6.13	19.63	21.37
Cash From Operations, 5 Yr. CAGR %	-5.7	-2.7	4.06	4.15	13.37
Capital Expenditures, 5 Yr. CAGR %	-46.25	-19.32	148.95	51.58	69.84
Levered Free Cash Flow, 5 Yr. CAGR %	-9.85	0.98	28.52	18.92	12.59
Unlevered Free Cash Flow, 5 Yr. CAGR %	-17.19	-4.23	34.03	34.55	23.73